nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Muscle spasms—Docetaxel—ovarian cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Gadobenate Dimeglumine—Infection—Paclitaxel—ovarian cancer	0.000654	0.000654	CcSEcCtD
Gadobenate Dimeglumine—Shock—Paclitaxel—ovarian cancer	0.000648	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vinorelbine—ovarian cancer	0.000648	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000646	0.000646	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Paclitaxel—ovarian cancer	0.000643	0.000643	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Paclitaxel—ovarian cancer	0.00064	0.00064	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000638	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—ovarian cancer	0.000637	0.000637	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000637	0.000637	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000634	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Docetaxel—ovarian cancer	0.000632	0.000632	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vinorelbine—ovarian cancer	0.000623	0.000623	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vinorelbine—ovarian cancer	0.000617	0.000617	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vinorelbine—ovarian cancer	0.000617	0.000617	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Paclitaxel—ovarian cancer	0.000616	0.000616	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vinorelbine—ovarian cancer	0.000614	0.000614	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Docetaxel—ovarian cancer	0.000614	0.000614	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—ovarian cancer	0.000613	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Docetaxel—ovarian cancer	0.000612	0.000612	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—ovarian cancer	0.000612	0.000612	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Docetaxel—ovarian cancer	0.000605	0.000605	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Docetaxel—ovarian cancer	0.000601	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.0006	0.0006	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Cough—Docetaxel—ovarian cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Paclitaxel—ovarian cancer	0.000591	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Docetaxel—ovarian cancer	0.000591	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—ovarian cancer	0.00059	0.00059	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—ovarian cancer	0.00059	0.00059	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—ovarian cancer	0.000589	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Paclitaxel—ovarian cancer	0.000587	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Paclitaxel—ovarian cancer	0.000586	0.000586	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Docetaxel—ovarian cancer	0.000582	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Docetaxel—ovarian cancer	0.000582	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Docetaxel—ovarian cancer	0.000582	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vinorelbine—ovarian cancer	0.000582	0.000582	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—ovarian cancer	0.00058	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Paclitaxel—ovarian cancer	0.00058	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000578	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—ovarian cancer	0.000574	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—ovarian cancer	0.000574	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Docetaxel—ovarian cancer	0.00057	0.00057	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000569	0.000569	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Paclitaxel—ovarian cancer	0.000568	0.000568	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Pain—Paclitaxel—ovarian cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Paclitaxel—ovarian cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—ovarian cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Docetaxel—ovarian cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000558	0.000558	CcSEcCtD
Gadobenate Dimeglumine—Infection—Docetaxel—ovarian cancer	0.000555	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000553	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Shock—Docetaxel—ovarian cancer	0.000549	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Docetaxel—ovarian cancer	0.000548	0.000548	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Docetaxel—ovarian cancer	0.000545	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000543	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Docetaxel—ovarian cancer	0.000542	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—ovarian cancer	0.00054	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000539	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000527	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—ovarian cancer	0.000524	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Paclitaxel—ovarian cancer	0.000523	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—ovarian cancer	0.000522	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—ovarian cancer	0.000522	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—ovarian cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Paclitaxel—ovarian cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Paclitaxel—ovarian cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—ovarian cancer	0.00052	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—ovarian cancer	0.000511	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000509	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—ovarian cancer	0.000501	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—ovarian cancer	0.000499	0.000499	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—ovarian cancer	0.000498	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—ovarian cancer	0.000496	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—ovarian cancer	0.000495	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—ovarian cancer	0.000491	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000488	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000485	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000483	0.000483	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000482	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000482	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—ovarian cancer	0.000479	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000478	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—ovarian cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—ovarian cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—ovarian cancer	0.000474	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—ovarian cancer	0.000473	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Paclitaxel—ovarian cancer	0.000473	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Paclitaxel—ovarian cancer	0.000466	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—ovarian cancer	0.000464	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—ovarian cancer	0.000461	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—ovarian cancer	0.000461	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—ovarian cancer	0.00046	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—ovarian cancer	0.000458	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—ovarian cancer	0.000457	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000457	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—ovarian cancer	0.000455	0.000455	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000455	0.000455	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—ovarian cancer	0.000452	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Paclitaxel—ovarian cancer	0.000451	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—ovarian cancer	0.000446	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—ovarian cancer	0.000445	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—ovarian cancer	0.000443	0.000443	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000442	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—ovarian cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—ovarian cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—ovarian cancer	0.000438	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Paclitaxel—ovarian cancer	0.000436	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—ovarian cancer	0.00043	0.00043	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000428	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—ovarian cancer	0.000426	0.000426	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Paclitaxel—ovarian cancer	0.000419	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—ovarian cancer	0.000418	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—ovarian cancer	0.000416	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Rash—Paclitaxel—ovarian cancer	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Paclitaxel—ovarian cancer	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—ovarian cancer	0.000414	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Headache—Paclitaxel—ovarian cancer	0.000413	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—ovarian cancer	0.000411	0.000411	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—ovarian cancer	0.000408	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—ovarian cancer	0.000406	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—ovarian cancer	0.000403	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—ovarian cancer	0.000401	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—ovarian cancer	0.000398	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000396	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—ovarian cancer	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—ovarian cancer	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—ovarian cancer	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Paclitaxel—ovarian cancer	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00039	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—ovarian cancer	0.000388	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—ovarian cancer	0.000385	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—ovarian cancer	0.000384	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—ovarian cancer	0.000383	0.000383	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—ovarian cancer	0.000382	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—ovarian cancer	0.000382	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—ovarian cancer	0.00038	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000375	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—ovarian cancer	0.000374	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—ovarian cancer	0.000373	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—ovarian cancer	0.000371	0.000371	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—ovarian cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—ovarian cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—ovarian cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—ovarian cancer	0.000368	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—ovarian cancer	0.000366	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—ovarian cancer	0.000363	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—ovarian cancer	0.000363	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—ovarian cancer	0.000363	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—ovarian cancer	0.000362	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—ovarian cancer	0.000359	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—ovarian cancer	0.000355	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—ovarian cancer	0.000355	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—ovarian cancer	0.000352	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—ovarian cancer	0.000352	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—ovarian cancer	0.000352	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—ovarian cancer	0.000351	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—ovarian cancer	0.00035	0.00035	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000348	0.000348	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—ovarian cancer	0.000346	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000343	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—ovarian cancer	0.000343	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000342	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—ovarian cancer	0.00034	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—ovarian cancer	0.000338	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—ovarian cancer	0.000338	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000337	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—ovarian cancer	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—ovarian cancer	0.000335	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—ovarian cancer	0.000332	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—ovarian cancer	0.000332	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—ovarian cancer	0.000326	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000325	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—ovarian cancer	0.000325	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—ovarian cancer	0.000322	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—ovarian cancer	0.000322	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000317	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—ovarian cancer	0.000313	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—ovarian cancer	0.000311	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—ovarian cancer	0.00031	0.00031	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—ovarian cancer	0.00031	0.00031	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—ovarian cancer	0.000307	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000301	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—ovarian cancer	0.0003	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—ovarian cancer	0.000299	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000287	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000285	0.000285	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—ovarian cancer	0.000277	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—ovarian cancer	0.000277	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—ovarian cancer	0.000275	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—ovarian cancer	0.000275	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—ovarian cancer	0.00027	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—ovarian cancer	0.000266	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—ovarian cancer	0.000258	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000257	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—ovarian cancer	0.00025	0.00025	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—ovarian cancer	0.000249	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—ovarian cancer	0.000247	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—ovarian cancer	0.000239	0.000239	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—ovarian cancer	0.000238	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—ovarian cancer	0.000237	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—ovarian cancer	0.000237	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—ovarian cancer	0.000236	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—ovarian cancer	0.00023	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—ovarian cancer	0.000224	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—ovarian cancer	0.000222	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—ovarian cancer	0.00022	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—ovarian cancer	0.00022	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—ovarian cancer	0.000218	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—ovarian cancer	0.000207	0.000207	CcSEcCtD
